Sandu [SANDUPHQ] vs Innova Captab [INNOVACAP] Detailed Stock Comparison

Sandu Pharmaceuticals, Inc.

BSE
Loading...

Innova Captab Ltd.

NSE
Loading...

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Sandu Pharmaceuticals, Inc. wins in 10 metrics, Innova Captab Ltd. wins in 10 metrics, with 0 ties. Both stocks appear equally matched on key metrics.

View Metrics Details

Vital Metrics Comparison

Metric Sandu Pharmaceuticals, Inc. Innova Captab Ltd. Better
P/E Ratio (TTM) 20.68 31.20 Sandu Pharmaceuticals, Inc.
Price-to-Book Ratio 1.00 4.05 Sandu Pharmaceuticals, Inc.
Debt-to-Equity Ratio 1.06 32.95 Sandu Pharmaceuticals, Inc.
PEG Ratio 0.27 1.33 Sandu Pharmaceuticals, Inc.
EV/EBITDA 14.48 20.49 Sandu Pharmaceuticals, Inc.
Profit Margin (TTM) 3.06% 8.85% Innova Captab Ltd.
Operating Margin (TTM) 4.66% 12.88% Innova Captab Ltd.
EBITDA Margin (TTM) 4.66% 12.88% Innova Captab Ltd.
Return on Equity 3.69% 13.37% Innova Captab Ltd.
Return on Assets (TTM) 2.78% 8.12% Innova Captab Ltd.
Free Cash Flow (TTM) $104,000 $-1.09B Sandu Pharmaceuticals, Inc.
Dividend Yield 1.61% 0.30% Sandu Pharmaceuticals, Inc.
1-Year Return -19.97% 3.87% Innova Captab Ltd.
Price-to-Sales Ratio (TTM) 0.63 2.76 Sandu Pharmaceuticals, Inc.
Enterprise Value $388.60M $43.41B Innova Captab Ltd.
EV/Revenue Ratio 0.58 2.90 Sandu Pharmaceuticals, Inc.
Gross Profit Margin (TTM) 57.96% 35.19% Sandu Pharmaceuticals, Inc.
Revenue per Share (TTM) $69 $262 Innova Captab Ltd.
Earnings per Share (Diluted) $2.11 $23.16 Innova Captab Ltd.
Beta (Stock Volatility) 0.07 -0.33 Innova Captab Ltd.

Sandu Pharmaceuticals, Inc. vs Innova Captab Ltd. Stock Performance Analysis

Loading Price Chart...

SANDUPHQ
INNOVACAP

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Sandu Pharmaceuticals, Inc.4.57%3.52%13.34%24.67%11.02%14.83%
Innova Captab Ltd.0.58%8.95%10.45%34.08%34.58%28.37%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Sandu Pharmaceuticals, Inc.-19.97%-28.02%-9.05%49.41%206.86%307.54%
Innova Captab Ltd.3.87%74.08%74.08%74.08%74.08%74.08%

Performance & Financial Health Analysis: Sandu Pharmaceuticals, Inc. vs Innova Captab Ltd.

MetricSANDUPHQINNOVACAP
Market Information
Market Cap i₹421.61M₹41.43B
Market Cap CategorySmall capSmall cap
10 Day Avg. Volume i7,699578,151
90 Day Avg. Volume i5,431217,693
Last Close₹43.51₹947.95
52 Week Range₹30.00 - ₹58.28₹622.00 - ₹978.00
% from 52W High-25.34%-3.07%
All-Time High₹86.00 (Apr 25, 2022)₹1,260.00 (Jan 06, 2025)
% from All-Time High-49.41%-24.77%
Growth Metrics
Quarterly Revenue Growth0.02%0.42%
Quarterly Earnings Growth0.76%0.23%
Financial Health
Profit Margin (TTM) i0.03%0.09%
Operating Margin (TTM) i0.05%0.13%
Return on Equity (TTM) i0.04%0.13%
Debt to Equity (MRQ) i1.0632.95
Cash & Liquidity
Book Value per Share (MRQ)₹43.50₹178.28
Cash per Share (MRQ)₹3.85₹10.22
Operating Cash Flow (TTM) i₹5.35M₹282.88M
Levered Free Cash Flow (TTM) i₹15.52M₹1.28B
Dividends
Last 12-Month Dividend Yield i1.61%0.30%
Last 12-Month Dividend i₹0.80₹2.00

Valuation & Enterprise Metrics Analysis: Sandu Pharmaceuticals, Inc. vs Innova Captab Ltd.

MetricSANDUPHQ (Apr 24, 2026)INNOVACAP (Apr 24, 2026)
Price Ratios
P/E Ratio (TTM) i20.6831.20
Forward P/E iN/A21.90
PEG Ratio i0.271.33
Price to Sales (TTM) i0.632.76
Price to Book (MRQ) i1.004.05
Market Capitalization
Market Capitalization i₹421.61M₹41.43B
Enterprise Value i₹388.60M₹43.41B
Enterprise Value Metrics
Enterprise to Revenue i0.582.90
Enterprise to EBITDA i14.4820.49
Risk & Other Metrics
Beta i0.07-0.33
Book Value per Share (MRQ) i₹43.50₹178.28

Financial Statements Comparison: Sandu Pharmaceuticals, Inc. vs Innova Captab Ltd.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricSANDUPHQ (2025)INNOVACAP (2025)
Revenue/Sales i671.92M12.34B
Cost of Goods Sold i332.04M8.38B
COGS % of Revenue i49.4%67.9%
Gross Profit i339.88M3.96B
Gross Margin i50.6%32.1%
Research & Development i2.33MN/A
Operating Income (EBIT) i20.94M1.65B
Operating Margin i3.1%13.4%
EBITDA i29.26M2.00B
EBITDA Margin i4.4%16.2%
Pre-Tax Income i21.59M1.71B
Pre-Tax Income % of Revenue i3.2%13.9%
Income Tax i6.07M427.58M
Income Tax % of Revenue i0.9%3.5%
Net Income (Profit) i15.52M1.28B
Profit Margin i2.3%10.4%

Balance Sheet & Liquidity Metrics

MetricSANDUPHQ (2025)INNOVACAP (2025)
Cash & Equivalents i13.04M155.19M
Total Current Assets i262.99M7.03B
Total Current Assets % of Revenue i39.1%57.0%
Total Current Liabilities i120.86M3.53B
Total Current Liabilities % of Revenue i18.0%28.6%
Long-Term Debt i4.19M2.45B
Long-Term Debt % of Revenue i0.6%19.8%
Total Shareholders Equity i420.17M9.59B
Retained Earnings i95.24M4.53B
Retained Earnings % of Revenue i14.2%36.7%
Property, Plant & Equipment i7.46M442.93M

Cash Flow Statement Comparison

MetricSANDUPHQ (2025)INNOVACAP (2025)
Operating Cash Flow i5.35M282.88M
Operating Cash Flow % of Revenue i0.8%2.3%
Capital Expenditures i-9.38M-1.72B
Free Cash Flow i104,000-1.09B
FCF Margin i0.0%-8.8%
Debt Repayment iN/A-114.03M
Common Stock Repurchase iN/AN/A

Short Interest & Institutional Ownership Analysis

MetricSANDUPHQINNOVACAP
Shares Short iN/AN/A
Short Ratio iN/AN/A
Short % of Float iN/AN/A
Shares Outstanding i9.66M57.22M
Float Shares i3.21M15.91M
% Held by Insiders i65.51%72.19%
% Held by Institutions i0.00%19.22%
% Held by Public i34.49%8.59%

Dividend Analysis & Yield Comparison: Sandu Pharmaceuticals, Inc. vs Innova Captab Ltd.

MetricSANDUPHQINNOVACAP
Last 12-Month Dividend i₹0.80₹2.00
Last 12-Month Dividend Yield i1.61%0.30%
3-Year Avg Annual Dividend i₹1.02₹0.67
3-Year Avg Dividend Yield i1.12%0.30%
3-Year Total Dividends i₹3.05₹2.00
Ex-Dividend DateSep 19, 2024Jan 30, 2026